Charles Schwab Investment Management »

Outlook Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $245k 33k 7.38
2024-03-31 $212k 18k 11.94

More positions owned by Charles Schwab Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Schwab Strategic Tr Fundamental Us L (FNDX)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Alphabet Cap Stk Cl C (GOOG)
Schwab Strategic Tr Fundamental Us S (FNDA)
Schwab Strategic Tr 5 10yr Corp Bd (SCHI)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Intl (FNDF)
Home Depot (HD)

View all positions for Charles Schwab Investment Management

Top funds holding Outlook Therapeutics

Dr. Jeffrey R. Jay, M.D.
Tang Capital Management
BlackRock
Sphera Funds Management
Vanguard Group
Altium Capital Management
Caligan Partners
Schonfeld Strategic Advisors
Geode Capital Management
State Street Corporation
Woodline Partners
LVW Advisors
Nuveen Asset Management
Susquehanna Fundamental Investments
Charles Schwab Investment Management

View all funds holding Outlook Therapeutics